Arrowhead Pharmaceuticals, Inc. (ARWR)

Healthcare · Biotechnology · NASDAQ

Arrowhead Pharmaceuticals, Inc. (ARWR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $10.15B and a free-cash-flow yield of 1.6%. Over the most recent reported fiscal year, revenue grew 23258.2%.

Market cap	$10.15B
Trailing P/E	—
FCF yield	1.6%
Revenue growth (YoY)	+23258.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ARWR data on Nama Insights →